Only Available By Prescription
Sign up to get notified if we do in the future.
We guarantee the lowest price on all of our prescription products. If you find your medications cheaper at any other recognized licensed mail order pharmacy, we will not only match their price, we will beat it by 25% of the difference. It is our 125% price match guarantee!
Example: If you find a product on Canada Drugs Direct for $50.00 and find the same product for $40.00 at another mail order pharmacy, we will provide you with a $12.50 discount, bringing your total to $37.50.
To get the discount please make sure to mention the price match to the customer service team when they call to collect payment for your order. Or call toll free at 1-888-904-8467 to place the order through the phone.
Terms & Conditions of Program
A generic drug is a copy of the brand-name drug with the same dosage, safety, strength, quality, consumption method, performance, and intended use. Before generics become available on the market, the generic company must prove it has the same active ingredients as the brand-name drug and works in the same way and in the same amount of time in the body.
The only differences between generics and their brand-name counterparts is that generics are less expensive and may look slightly different (eg. different shape or color), as trademarks laws prevent a generic from looking exactly like the brand-name drug.
Generics are less expensive because generic manufacturers don't have to invest large sums of money to develop a drug. When the brand-name patent expires, generic companies can manufacture a copy of the brand-name and sell it at a substantial discount.
Ocrevus (ocrelizumab) is a medication given via intravenous infusion for the treatment of multiple sclerosis.
| Fact Table | |
| Formula | C6496H10052N1732O2022S42 |
| License | US FDA, EMA |
| Bioavailability | Not applicable (IV only) |
| Legal status | Prescription only (Rx) |
| Chemical Name | Ocrelizumab |
| Elimination half-life | 26 days (range: 14–42 days) |
| Dosage (Strength) | 300 mg/10 mL (first dose split in two infusions); then 600 mg IV every 6 months |
| Pregnancy | Avoid use; may cross placenta (IgG1 subclass) |
| Brands | Ocrevus |
| Protein binding | High (monoclonal antibody) |
| PubChem CID | 86278376 |
| MedlinePlus | a617007 |
| ChEBI | 133754 |
| ATC code | L04AA36 |
| DrugBank | DB11963 |
| KEGG | D10745 |
| Routes of administration | Intravenous (IV) |
Your dosage and treatment duration will be determined by your healthcare provider.
Ocrevus will be administered by your healthcare provider, as well as a steroid and an antihistamine prior Ocrevus administration.
Inform your healthcare provider of any questions or concerns you may have.
The active ingredient in Ocrevus is ocrelizumab. Glacial acetic acid, polysorbate 20, sodium acetate trihydrate, and trehalose dihydrate are the inactive ingredients.
Some patients should not receive Ocrevus, including those who have hepatitis B or have ever had a life-threatening infusion reaction to Ocrevus.
Ocrevus infusion side effects include but are not limited to upper respiratory tract infections, infusion reactions, skin infections, and lower respiratory tract infections. Inform your healthcare provider right away if you develop bothersome or persistent side effects.
Talk to your healthcare provider about Ocrevus.
Ocrevus. South San Francisco, CA: Genentech, Inc.; 2023.
Exceptional Customer Service
We pride ourselves on delivering excellent customer service with as much accessibility as possible.
If you have any questions at all, or would like to place an order, you are encouraged to contact us by toll-free
phone 1-888-904-8467 or email info@canadadrugsdirect.com.
Top Safety and Quality
Canada Drugs Direct employs dedicated, professional licensed pharmacists to ensure that each and every order is reviewed before it is dispensed for the safety and health of our customers. At CanadaDrugsDirect.com, your health is our top priority.
Product Reviews